Researcher Spotlight: Selina Chen-Kiang, PhD Weill Cornell Lymphoma Research Foundation (LRF)- supported research may have identified both the molecular mechanism that causes some mantle cell lymphoma (MCL) patients to be resistant to ibrutinib (Imbruvica), and ways to overcome that resistance.…
Researcher Spotlight: Elias Campo, MD, PhD Hospital Clinic of the University of Barcelona in Spain Dr. Campo is Research Director and Professor of Anatomic Pathology at the Hospital Clinic of the University of Barcelona in Spain. He and his colleagues…
Researcher Spotlight: Laurence Cooper, MD, PhD MD Anderson Lymphoma Research Foundation (LRF) grantee Dr. Laurence Cooper is passionate about using the body’s immune system to fight lymphoma. He helped conduct the first in-human clinical trial of adoptive immunotherapy for patients…
Researcher Spotlight: John P. Leonard, MD Weill Cornell Medicine Chemotherapy is an effective strategy in treating many lymphoma patients, however, its toxicity and the growing number of effective novel therapies for lymphoma has prompted researchers to explore chemotherapy-free options…
Researcher Spotlight: Peter Riedell, MD Washington University in Saint Louis Dr. Riedell’s Lymphoma Clinical Research Mentoring Program (LCRMP) project focuses on mantle cell lymphoma (MCL). Noting that recent research has indicated Bruton’s tyrosine kinase (BTK) inhibitors (such as ibrutinib)…
Researcher Spotlight: Sami Malek, MD University of Michigan School of Medicine Dr. Malek, an Associate Professor at the University of Michigan School of Medicine, received a Chronic Lymphocytic Leukemia (CLL) Collaborative Grant from the Lymphoma Research Foundation (LRF) in…
Researcher Spotlight: Catherine Wu, MD Stanford School of Medicine “I have always been interested in understanding the ‘why’ of how disease arises, and have always felt strongly that doing so is the most effective way of devising truly effective treatments,”…
Researcher Spotlight: Hans-Guido Wendel, MD Memorial Sloan Kettering Cancer Center Translational research transforms scientific discoveries that occur in the laboratory into new treatments for lymphoma and other types of cancer. This important step in the search for new therapies for…
Researcher Spotlight: Samuel Katz, MD, PhD Yale University Dr. Katz, an Assistant Professor of Pathology at Yale University, recently completed work on research funded by a Lymphoma Research Foundation (LRF) Mantle Cell Lymphoma Developmental/Exploratory Grant. As researchers have learned more…
Researcher Spotlight: Neil Kay, MD Mayo Clinic A prognostic index is a clinical tool used by oncologists to predict the duration, function, and disease progression for a patient with a particular type of cancer. As researchers have learned more about…